BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34179725)

  • 1. A murine model of tuberculosis/type 2 diabetes comorbidity for investigating the microbiome, metabolome and associated immune parameters.
    Sathkumara HD; Eaton JL; Field MA; Govan BL; Ketheesan N; Kupz A
    Animal Model Exp Med; 2021 Jun; 4(2):181-188. PubMed ID: 34179725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes.
    Alim MA; Kupz A; Sikder S; Rush C; Govan B; Ketheesan N
    Microbes Infect; 2020 Sep; 22(8):303-311. PubMed ID: 32234542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
    Sathkumara HD; Muruganandah V; Cooper MM; Field MA; Alim MA; Brosch R; Ketheesan N; Govan B; Rush CM; Henning L; Kupz A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20848-20859. PubMed ID: 32778586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
    López-Torres MO; Marquina-Castillo B; Ramos-Espinosa O; Mata-Espinosa D; Barrios-Payan JA; Baay-Guzman G; Yepez SH; Bini E; Torre-Villalvazo I; Torres N; Tovar A; Chamberlin W; Ge Y; Carranza A; Hernández-Pando R
    Clin Exp Immunol; 2021 Aug; 205(2):232-245. PubMed ID: 33866550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
    Negi S; Pahari S; Bashir H; Agrewala JN
    Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure.
    Cadena AM; Ma Y; Ding T; Bryant M; Maiello P; Geber A; Lin PL; Flynn JL; Ghedin E
    Microbiome; 2018 Oct; 6(1):180. PubMed ID: 30301469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity.
    Bui TI; Gill AL; Mooney RA; Gill SR
    Microbiol Spectr; 2022 Apr; 10(2):e0017022. PubMed ID: 35315698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis.
    Khan N; Vidyarthi A; Nadeem S; Negi S; Nair G; Agrewala JN
    Front Immunol; 2016; 7():529. PubMed ID: 27965663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut and lung microbiota in pulmonary tuberculosis: susceptibility, function, and new insights into treatment.
    Zhuo Q; Zhang X; Zhang K; Chen C; Huang Z; Xu Y
    Expert Rev Anti Infect Ther; 2023; 21(12):1355-1364. PubMed ID: 37970631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-Testis Axis: Microbiota Prime Metabolome To Increase Sperm Quality in Young Type 2 Diabetes.
    Yan X; Feng Y; Hao Y; Zhong R; Jiang Y; Tang X; Lu D; Fang H; Agarwal M; Chen L; Zhao Y; Zhang H
    Microbiol Spectr; 2022 Oct; 10(5):e0142322. PubMed ID: 36214691
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Meng R; Dong W; Gao J; Lu C; Zhang C; Liao Q; Chen L; Wu H; Hu J; Wei W; Jiang Z
    Indian J Microbiol; 2022 Sep; 62(3):374-383. PubMed ID: 35974910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes.
    Huang HL; Luo YC; Lu PL; Huang CH; Lin KD; Lee MR; Cheng MH; Yeh YT; Kao CY; Wang JY; Yang JM; Chong IW
    Respir Res; 2023 Jan; 24(1):11. PubMed ID: 36631857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
    Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against
    Negi S; Pahari S; Bashir H; Agrewala JN
    Front Immunol; 2019; 10():1142. PubMed ID: 31231363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the gut-lung axis on tuberculosis susceptibility and progression.
    Enjeti A; Sathkumara HD; Kupz A
    Front Microbiol; 2023; 14():1209932. PubMed ID: 37485512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
    Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
    J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiota mediates protective immunity against tuberculosis
    Yang F; Yang Y; Chen L; Zhang Z; Liu L; Zhang C; Mai Q; Chen Y; Chen Z; Lin T; Chen L; Guo H; Zhou L; Shen H; Chen X; Liu L; Zhang G; Liao H; Zeng L; Zeng G
    Gut Microbes; 2022; 14(1):2029997. PubMed ID: 35343370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances.
    Osei Sekyere J; Maningi NE; Fourie PB
    Ann N Y Acad Sci; 2020 May; 1467(1):21-47. PubMed ID: 31989644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.